Showing results (41-50 of 400) with videos related to
Sort By:
Pageof 40
Heart Failure Reviews|November 20, 2014
Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugsAdam Castaño, Brian M Drachman, Daniel Judge, et al.Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|October 4, 2005
Ventricular volume and length in hypertensive diastolic heart failureMathew S Maurer, Lyna El Khoury Rumbarger, Donald L KingThe American Journal of Cardiology|September 13, 2014
Prevalence and prognostic significance of low QRS voltage among the three main types of cardiac amyloidosisNicole B Cyrille, Jeff Goldsmith, Julissa Alvarez, et al.Current Cardiovascular Risk Reports|October 24, 2017
Transthyretin Cardiac Amyloidosis in Older Adults: Optimizing Cardiac Imaging to the Corresponding Diagnostic and Management GoalAdam Castaño, Daniel K Manson, Mathew S Maurer, et al.Current Cardiovascular Risk Reports|July 18, 2017
Gerontechnologies for Older Patients with Heart Failure: What is the Role of Smartphones, Tablets, and Remote Monitoring Devices in Improving Symptom Monitoring and Self-Care Management?Ruth M Masterson Creber, Kathleen T Hickey, Mathew S MaurerAging Health|September 28, 2013
Comparison of cardiac amyloidosis due to wild-type and V122I transthyretin in older adults referred to an academic medical centerRaymond C Givens, Chris Russo, Philip Green, et al.Congestive Heart Failure (Greenwich, Conn.)|January 29, 2011
Blood volume measurements in patients with heart failure and a preserved ejection fraction: implications for diagnosing anemiaBassel Noumi, Sergio Teruya, Say Salomon, et al.Circulation. Heart Failure|December 22, 2012
Treating anemia in older adults with heart failure with a preserved ejection fraction with epoetin alfa: single-blind randomized clinical trial of safety and efficacyMathew S Maurer, Sergio Teruya, Bibhas Chakraborty, et al.Journal of Cardiac Failure|October 16, 2013
Differences in blood volume components between hyporesponders and responders to erythropoietin alfa: the heart failure with preserved ejection fraction (HFPEF) anemia trialMargarita Borovka, Sergio Teruya, Julissa Alvarez, et al.Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|February 9, 2017
18Fluorine sodium fluoride positron emission tomography, a potential biomarker of transthyretin cardiac amyloidosisRachelle Morgenstern, Randy Yeh, Adam Castano, et al.Pageof 40